文献速递胃肠外科围术期管理与 ERAS

手术方式对食管癌切除术围手术期及长期结局的影响

Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer.
PubMed 文献 · Surg Endosc · 2017-10-24

该回顾性单中心研究比较了2001至2015年间开放食管切除术(OE)与微创Ivor Lewis食管切除术(MIE)的围手术期及肿瘤学结局。MIE与更好的淋巴结获取数、更少的术中出血、更短住院时间和更少导致再手术或ICU入院的严重不良事件相关;倾向性评分匹配后两组总生存和无病生存无显著差异。

要点

  • MIE组淋巴结获取数更多(30 vs 14,p<0.001),术中出血更少(312 mL vs 657 mL,p<0.001)。
  • MIE组中位住院时间更短(10天 vs 14天,p<0.01),严重不良事件导致再手术或ICU入院的比例更低(21% vs 34%,p<0.01)。
  • 匹配分析显示MIE与OE的总生存和无病生存无显著差异。

核心结论

  • MIE与更好的围手术期结局相关,包括更少术中出血、更高淋巴结获取数、更低严重不良事件风险和更短住院时间。
  • 尽管围手术期优势明显,MIE与OE的长期肿瘤学结局相似。

研究设计与样本

  • 回顾性单中心研究,纳入2001至2015年间接受MIE或OE的食管癌患者。
  • 共分析291例食管切除术患者,其中OE占47%(137/291),MIE占25%(73/291)。
  • 采用Cox回归多变量分析、Kaplan-Meier法和倾向性评分匹配(69对)比较结局。

主要发现

  • MIE组淋巴结获取数中位30(IQR 22-39),OE组14(IQR 7-19),p<0.001。
  • MIE组术中出血量中位312 mL(IQR 100-400),OE组657 mL(IQR 350-700),p<0.001。
  • MIE组中位住院时间10天(IQR 8-14),OE组14天(IQR 11-22),p<0.01。
  • 严重不良事件导致再手术或ICU入院:MIE组21%,OE组34%,p<0.01。
  • 匹配分析中位总生存:MIE 49个月(18-67),OE 29个月(17-69),p=0.26;中位无病生存:MIE 9个月(6-22),OE 13个月(6-22),p=0.45。

关键数值与推荐

  • 多变量分析显示年龄和切缘阳性与生存几率降低相关。
  • 淋巴结获取数、切缘阳性和病理分期是无病生存的显著预测因素。

临床怎么用

  • 在条件允许时,MIE可作为食管癌切除术的优选方式,以改善围手术期结局。
  • MIE获得的更高淋巴结获取数可能有利于肿瘤学评估,但需结合长期随访确认。

局限性

  • 回顾性单中心设计,存在选择偏倚可能。
  • OE组接受新辅助放化疗的患者较少,可能影响结局比较。
  • 样本量有限,匹配后仅69对,长期生存分析可能把握度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical resection remains a critical component of esophageal cancer treatment with curative-intent. The aim of this study was to compare open (OE) to minimally invasive Ivor Lewis esophagectomy (MIE) with respect to perioperative and oncologic outcomes. METHODS: Retrospective single-institution review of MIE and OE patients operated between 2001 and 2015 was conducted. Univariable and multivariable models were created using Cox regression. The Kaplan-Meier method was used to compare oncologic outcomes. Propensity score matching was used to compare oncological outcomes in MIE and OE patients. RESULTS: Of 210 esophageal resection patients, 47% had OE (137/291) and 25% had MIE (73/291). The MIE and OE groups were comparable with respect to patient factors and operative details. Fewer OE patients received neoadjuvant chemoradiation. MIE was associated with improved lymph node yield, (MIE = 30 [IQR:22-39]; OE = 14 [IQR:7-19], p < 0.001), less intraoperative blood loss (MIE = 312 mL [100-400]; OE = 657 mL [350-700], p < 0.001), and shorter median length of stay (MIE = 10 days [IQR = 8-14]; OE = 14 days [IQR = 11-22] p < 0.01). The OE group had significantly more adverse events resulting in reoperation or intensive care unit admission (MIE = 21%; OE = 34%; p < 0.01). On multivariable analysis, age and positive resection margins were associated with decreased odds of survival. The number of lymph nodes retrieved, positive resection margins, and pathologic stage were significant predictors of disease-free survival. Analysis of 69 matched pairs showed equivalent median overall survival (MIE = 49 months [18-67]; OE = 29 months [17-69]; p = 0.26) and disease-free survival (MIE = 9 [6-22]; OE = 13 [6-22]; p = 0.45) between the two groups. CONCLUSIONS: Although long-term oncologic outcomes appear to be similar, MIE is associated with significantly less intraoperative blood loss, improved lymph node yield, less risk of severe postoperative adverse events, and shorter length of stay.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ahmadi N, Crnic A, Seely AJ, et al. Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer. Surg Endosc. 2017. PMID: 29067584. doi:10.1007/s00464-017-5881-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。